Edwards Lifesciences Corporatio (EW) Financials
EW Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 9.7 billion | 2.5 billion |
2023-12-31 | 9.4 billion | 2.6 billion |
2023-09-30 | 9.4 billion | 2.6 billion |
2023-06-30 | 9.0 billion | 2.6 billion |
EW Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | -138.8 million | 44.6 million |
2023-12-31 | 35.0 million | 30.5 million |
2023-09-30 | 356.2 million | 32.6 million |
2023-06-30 | -14.3 million | 37.4 million |
EW Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2024-03-31 | 351.0 million |
2023-12-31 | 369.7 million |
2023-09-30 | 383.7 million |
2023-06-30 | 305.5 million |
EW Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 1.7 billion | - | 102.0 million |
2023-12-31 | 1.6 billion | - | 97.9 million |
2023-09-30 | 1.9 billion | 596.8 million | 94.3 million |
2023-06-30 | 1.5 billion | 596.7 million | 87.8 million |
EW Shares Outstanding
EW Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 85.3 million | 285.2 million | 489.7 million | - |
2023-12-31 | 101.6 million | 270.0 million | 478.8 million | - |
2023-09-30 | 55.3 million | 270.3 million | 439.6 million | - |
2023-06-30 | 47.9 million | 270.3 million | 468.7 million | - |
EW Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 1.6 billion | 384.2 million |
2023-12-31 | 1.5 billion | 356.9 million |
2023-09-30 | 1.5 billion | 350.4 million |
2023-06-30 | 1.5 billion | 343.0 million |
EW
Price: $88.13
52 week price:
Earnings Per Share: 2.32 USD
P/E Ratio: 37.38
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Volume: 2.2 million
Ebitda: 328.1 millionMarket Capitalization: 52.3 billion